Merck Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck Limited with three other
companies in this sector in India:
sales of 8.89 billion Indian Rupees [US$130.37 million]
of which 100%
Novartis India Limited
(8.73 billion Indian Rupees [US$128.04 million]
of which 69%
was Pharmaceuticals), and
(8.72 billion Indian Rupees [US$127.81 million]
of which 62%
was Pharmaceutical Products).
Merck Limited reported sales of 9.40 billion Indian Rupees (US$137.73 million)
December of 2015.
increase of 8.3%
versus 2014, when the company's sales were 8.67 billion Indian Rupees.
Sales at Merck Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 85%).
Sales of Pharmaceuticals saw an increase
13.8% in 2015, from
5.85 billion Indian Rupees to 6.66 billion Indian Rupees.
Not all segments of Merck Limited experienced an increase in sales in 2015:
sales of Chemicals fell 3.1% to 2.74 billion Indian Rupees.